loading
Schlusskurs vom Vortag:
$2.85
Offen:
$2.66
24-Stunden-Volumen:
6,149
Relative Volume:
0.01
Marktkapitalisierung:
$357.09M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-18.86M
KGV:
-0.1725
EPS:
-16.054
Netto-Cashflow:
$-17.68M
1W Leistung:
-10.67%
1M Leistung:
-26.78%
6M Leistung:
-0.37%
1J Leistung:
-75.88%
1-Tages-Spanne:
Value
$2.6311
$2.75
1-Wochen-Bereich:
Value
$2.61
$3.21
52-Wochen-Spanne:
Value
$0.92
$13.40

Indaptus Therapeutics Inc Stock (INDP) Company Profile

Name
Firmenname
Indaptus Therapeutics Inc
Name
Telefon
(646) 427-2727
Name
Adresse
3 COLUMBUS CIRCLE, NEW YORK
Name
Mitarbeiter
5
Name
Twitter
Name
Nächster Verdiensttermin
2026-08-12
Name
Neueste SEC-Einreichungen
Name
INDP's Discussions on Twitter

Compare INDP vs VRTX, REGN, ARGX, ALNY, RVMD

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
INDP icon
INDP
Indaptus Therapeutics Inc
2.68 399.73M 0 -18.86M -17.68M -16.05
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
519.88 126.07B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
661.27 65.37B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
927.55 57.70B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
316.88 40.19B 4.29B 577.22M 641.34M 4.2086
RVMD icon
RVMD
Revolution Medicines Inc
187.82 39.82B 742.00K -1.37B -1.07B -7.0731

Indaptus Therapeutics Inc Aktie (INDP) Neueste Nachrichten

pulisher
Jun 29, 2026

Indaptus Therapeutics (INDP) News Flow - Moomoo

Jun 29, 2026
pulisher
Jun 27, 2026

Indaptus Therapeutics Company Profile & Introduction - Moomoo

Jun 27, 2026
pulisher
Jun 27, 2026

Form 13D/A Indaptus Therapeutics For: 26 June By Investing.com - Investing.com Australia

Jun 27, 2026
pulisher
Jun 26, 2026

Sino Lion Ventures (INDP) files amended 13D on 38,895,000 shares - Stock Titan

Jun 26, 2026
pulisher
Jun 26, 2026

Indaptus Therapeutics (INDP) CEO details 8.44% common stock stake - Stock Titan

Jun 26, 2026
pulisher
Jun 26, 2026

Indaptus (INDP) investor Ting Yang stake falls to 8.44% after share issuance - Stock Titan

Jun 26, 2026
pulisher
Jun 26, 2026

Form S-3 Indaptus Therapeutics Inc For: 26 June By Investing.com - Investing.com South Africa

Jun 26, 2026
pulisher
Jun 26, 2026

Indaptus Therapeutics (INDP) registers 18.864M shares; clinical program paused - Stock Titan

Jun 26, 2026
pulisher
Jun 25, 2026

Revenue per share of Indaptus Therapeutics, Inc. – NASDAQ:INDP - TradingView

Jun 25, 2026
pulisher
Jun 24, 2026

INDAPTUS THERAPEUTICSTO ISSUE 20 MLN SHARES AT $0.6 PER SHARESEC FILING - Moomoo

Jun 24, 2026
pulisher
Jun 24, 2026

Indaptus TherapeuticsTo Issue 20 Million Shares At $0.6 Per ShareSEC Filing - TradingView

Jun 24, 2026
pulisher
Jun 24, 2026

Indaptus Therapeutics Announces Private Placement of Common Stock - TipRanks

Jun 24, 2026
pulisher
Jun 24, 2026

Indaptus Therapeutics (INDP) sells 20M shares in $12M Regulation S private placement - Stock Titan

Jun 24, 2026
pulisher
Jun 24, 2026

Indaptus Therapeutics Raises $12 Million in Offshore Private Placement at $0.60 Per Share - TradingView

Jun 24, 2026
pulisher
Jun 23, 2026

Indaptus Therapeutics Inc (INDP) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jun 23, 2026
pulisher
Jun 22, 2026

Form PRE 14A Sunshine Biopharma Inc For: 22 June By Investing.com - Investing.com Australia

Jun 22, 2026
pulisher
Jun 22, 2026

Indaptus Therapeutics (INDP) asks shareholders to approve $300M PIPE, equity plan - Stock Titan

Jun 22, 2026
pulisher
Jun 22, 2026

Indaptus Therapeutics Inc (INDP) Institutional Confidence - TradingKey

Jun 22, 2026
pulisher
Jun 18, 2026

Indaptus Therapeutics Inc (INDP) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jun 18, 2026
pulisher
Jun 18, 2026

Indaptus Therapeutics Inc (INDP) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jun 18, 2026
pulisher
Jun 18, 2026

Indaptus Therapeutics Inc (INDP) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jun 18, 2026
pulisher
Jun 18, 2026

Indaptus Therapeutics Inc (INDP) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jun 18, 2026
pulisher
Jun 18, 2026

Indaptus Therapeutics Inc (INDP) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jun 18, 2026
pulisher
Jun 18, 2026

Indaptus Therapeutics Inc (INDP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jun 18, 2026
pulisher
Jun 18, 2026

Indaptus Therapeutics Inc (INDP) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jun 18, 2026
pulisher
Jun 18, 2026

Top Cue Biopharma (CUE) Competitors 2026 - MarketBeat

Jun 18, 2026
pulisher
Jun 17, 2026

Abbott Cooper PLLC Announces Investigation on Behalf of Indaptus Therapeutics, Inc. Stockholders - Caledonian Record

Jun 17, 2026
pulisher
Jun 16, 2026

Indaptus Therapeutics, Inc. announced that it expects to receive $12 million in funding - marketscreener.com

Jun 16, 2026
pulisher
Jun 13, 2026

INDP Q4 2025 Earnings: EPS Misses Estimates Amid Continued R&D InvestmentNet Income Trends - newsline.com

Jun 13, 2026
pulisher
Jun 11, 2026

12 Health Care Stocks Moving In Thursday's Intraday SessionAdial Pharmaceuticals (NASDAQ:ADIL), Aditxt - Benzinga

Jun 11, 2026
pulisher
Jun 10, 2026

12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga

Jun 10, 2026
pulisher
Jun 08, 2026

INDP Q4 2025 Earnings: EPS Misses Estimates, Stock Tumbles 42.62%Quarterly Earnings Report - newsline.com

Jun 08, 2026
pulisher
Jun 08, 2026

Indaptus Therapeutics (INDP) Plunges 42% as Selling Pressure IntensifiesUp Down Volume - newsline.com

Jun 08, 2026
pulisher
Jun 08, 2026

12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga

Jun 08, 2026
pulisher
Jun 06, 2026

Indaptus Therapeutics, Inc. Files Form 8-K Announcing CEO Change – Junyi Dai Appointed CEO - Minichart

Jun 06, 2026
pulisher
Jun 05, 2026

Indaptus Therapeutics Announces Recent Board and Leadership Changes - TipRanks

Jun 05, 2026
pulisher
Jun 05, 2026

Indaptus Therapeutics directors David E. Lazar and Avraham Ben-Tzvi resign; Walt A. Linscott steps down as COO - TradingView

Jun 05, 2026
pulisher
Jun 05, 2026

Leadership shifts at Indaptus Therapeutics (NASDAQ: INDP) as directors and COO exit - Stock Titan

Jun 05, 2026
pulisher
Jun 05, 2026

12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga

Jun 05, 2026
pulisher
Jun 04, 2026

Indaptus Therapeutics (INDP) Jumps 53.8% Amid Heavy Volume as Investors Focus on Financing/strategic-option Uncertainty - Moomoo

Jun 04, 2026
pulisher
Jun 04, 2026

Indaptus Therapeutics (INDP) jumps 53.8% amid heavy volume as investors focus on financing/strategic-option uncertainty - Quiver Quantitative

Jun 04, 2026
pulisher
May 29, 2026

INDPIndaptus Therapeutics Inc Stock Price and Quote - Finviz

May 29, 2026
pulisher
May 29, 2026

INDP Q4 2025 Earnings: Wider-Than-Expected Loss as Clinical-Stage Biotech Focuses on Pipeline MilestonesMargin Expansion Trends - newsline.com

May 29, 2026
pulisher
May 26, 2026

Indaptus Therapeutics Drops on Cash Runway Worries - Bez Kabli

May 26, 2026
pulisher
May 26, 2026

Indaptus Therapeutics Inc. (INDP) Plunges 9.8% as Shares Approach Key Support ZoneGap Down Bounce Plays - Newser

May 26, 2026
pulisher
May 26, 2026

INDP Q4 2025 Earnings: EPS Misses Estimates as Pre-Clinical Costs Continue, Stock Declines 9%Revenue Growth Outlook - newsline.com

May 26, 2026
pulisher
May 25, 2026

Indaptus Therapeutics Q4 2025 Earnings: EPS Misses Estimates on Minimal Revenue, Stock SurgesFree Cash Flow Trends - The Legal Advocate

May 25, 2026
pulisher
May 24, 2026

Indaptus Therapeutics Inc. (INDP) Q4 2025 Earnings: Deeper Loss, Yet Shares Surge on Pipeline ProgressRevenue Warning Signal - Newser

May 24, 2026
pulisher
May 22, 2026

Indaptus Therapeutics (INDP) Surges 15%: Biotech Stock Breaks Above Key ResistanceMarket Hype Signals - Newser

May 22, 2026
pulisher
May 16, 2026

Earnings Scheduled For May 15, 2026 - Sahm

May 16, 2026
pulisher
May 15, 2026

Indaptus Therapeutics, Inc. Reports Substantial Doubt About Going Concern and Highlights Key Risks in Q1 2026 10-Q Filing - Minichart

May 15, 2026

Finanzdaten der Indaptus Therapeutics Inc-Aktie (INDP)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$113.18
price up icon 1.95%
$35.27
price up icon 0.23%
$58.09
price down icon 0.07%
ONC ONC
$305.00
price down icon 0.85%
$82.23
price up icon 0.32%
$190.47
price up icon 0.31%
Kapitalisierung:     |  Volumen (24h):